| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |